The PE35-MU2 Conjugate selectively and potently killed PSMA-expressing prostate cancer lines at low nanomolar concentrations and was ~ 30-fold more toxic to PSMA[+] vs. PSMA[−] prostate cancer cells. The gene discussed is FOLH1; the disease is Familial prostate cancer.